Use of the optimal dose of ARBs in hypertension and CV diseases Ass. Prof. Roland KASSAB Head of Division of Cardiology HDF, Beirut 12/02/2005.
CHAPTER Cardiac Evaluation Pulmonary Evaluation Periop Beta Blockers SBE Prophylaxis DVT Prophylaxis Periop Medication Management Management of Longterm.
Heartbeat – ESC 2004 ESC 2004 ESC 2004: Learning as a journey Valentin Fuster MD Director, Cardiovascular Institute Mount Sinai Medical Center New York,
Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed TOmographic Angiography: The DeFACTO Study James K. Min 1 ; Jonathon Leipsic 2 ;
Pre-Exercise Assessments KNR 240 Fall 04. Rationale for pre-testing and screening Nearly 75,000 Americans suffer a MI during or after exercise each.
ACSM’s Guidelines For Exercise Testing And Prescription : Chapter 2 Health Screening & Risk Stratification David Arnall, Ph.D., P.T., FACSM, ES.
Asymptomatic Carotid Surgery Trial ACST-2 Collaborators Meeting 2014 Pembroke College, Oxford Is recent coronary stenting a problem (or an opportunity)
Scranton Heart Institute, P.C. Anti-Platelet Medications For Elective Percutaneous Coronary Interventional Procedures - 2011 Stafford M. Smith, M.D., FACP,
Assessing the Impact of Medication Adherence on Long-term Outcomes Post Myocardial Infarction S. Bansilal, JM. Castellano, HG. Wei, E. Garrido, A. Freeman,
Chapter 3 Health Appraisal. Evaluating Health Status Categories M edical history review R isk factor assessment and stratification P rescribed medications.
Results of Monotherapy in ALLHAT: On-treatment Analyses ALLHAT Outcomes for participants who received no step-up drugs.
Pt assigned to CABG is in yellow Pt assigned to PTCA is in blue Diabetics benefited from CABG than from PTCA alone, evidenced by 75% 6year survivabilit.